{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:02:44Z","timestamp":1784991764369,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hamburger Krebsgesellschaft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00784-018-2751-0","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T16:32:26Z","timestamp":1543509146000},"page":"3319-3329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["ERCC1, XPF and XPA\u2014locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0324-4601","authenticated-orcid":false,"given":"Sebastian","family":"Prochnow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Muenscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"2751_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329","journal-title":"CA Cancer J Clin"},{"key":"2751_CR2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137\u20132150","journal-title":"J Clin Oncol"},{"key":"2751_CR3","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/bjc.2013.576","volume":"109","author":"JE Bauman","year":"2013","unstructured":"Bauman JE, Austin MC, Schmidt R, Kurland BF, Vaezi A, Hayes DN, Mendez E, Parvathaneni U, Chai X, Sampath S, Martins RG (2013) ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer 109:2096\u20132105","journal-title":"Br J Cancer"},{"key":"2751_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92\u201398","journal-title":"J Clin Oncol"},{"key":"2751_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"2751_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0936-6555(05)80064-0","volume":"9","author":"JM Henk","year":"1997","unstructured":"Henk JM (1997) Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) 9:308\u2013312","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2751_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253\u2013262","journal-title":"Radiother Oncol"},{"key":"2751_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261\u2013269","journal-title":"J Natl Cancer Inst"},{"key":"2751_CR9","first-page":"4899","volume":"62","author":"T Furuta","year":"2002","unstructured":"Furuta T, Ueda T, Aune G, Sarasin A, Kraemer KH, Pommier Y (2002) Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res 62:4899\u20134902","journal-title":"Cancer Res"},{"key":"2751_CR10","doi-asserted-by":"publisher","first-page":"9990","DOI":"10.1093\/nar\/gks818","volume":"40","author":"EM McNeil","year":"2012","unstructured":"McNeil EM, Melton DW (2012) DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res 40:9990\u201310004","journal-title":"Nucleic Acids Res"},{"key":"2751_CR11","first-page":"3223","volume":"30","author":"K Kirschner","year":"2010","unstructured":"Kirschner K, Melton DW (2010) Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Anticancer Res 30:3223\u20133232","journal-title":"Anticancer Res"},{"key":"2751_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0194599813496522","volume":"149","author":"MR Patel","year":"2013","unstructured":"Patel MR, Zhao N, Ang MK, Stadler ME, Fritchie K, Weissler MC, Zanation AM, Harris SL, Funkhouser WK, Olshan AF, Shores CG, Hayes DN (2013) ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149:587\u2013595","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2751_CR13","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/emboj\/21.8.2045","volume":"21","author":"JH Enzlin","year":"2002","unstructured":"Enzlin JH, Scharer OD (2002) The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. EMBO J 21:2045\u20132053","journal-title":"EMBO J"},{"key":"2751_CR14","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1074\/jbc.M109.067538","volume":"285","author":"B Orelli","year":"2010","unstructured":"Orelli B, McClendon TB, Tsodikov OV, Ellenberger T, Niedernhofer LJ, Scharer OD (2010) The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways. J Biol Chem 285:3705\u20133712","journal-title":"J Biol Chem"},{"key":"2751_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.bjc.6604464","volume":"99","author":"HJ Jun","year":"2008","unstructured":"Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, Ahn YC, Jeong HS, Son YI, Baek JH, Park K (2008) ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 99:167\u2013172","journal-title":"Br J Cancer"},{"key":"2751_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejca.2007.09.006","volume":"44","author":"MK Kim","year":"2008","unstructured":"Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Kim SB (2008) ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer 44:54\u201360","journal-title":"Eur J Cancer"},{"key":"2751_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/annonc\/mdl430","volume":"18","author":"HC Kwon","year":"2007","unstructured":"Kwon HC, Roh MS, Oh SY, Kim SH, Kim MC, Kim JS, Kim HJ (2007) Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil\/oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 18:504\u2013509","journal-title":"Ann Oncol"},{"key":"2751_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2407-8-97","volume":"8","author":"L Wang","year":"2008","unstructured":"Wang L, Wei J, Qian X, Yin H, Zhao Y, Yu L, Wang T, Liu B (2008) ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and\/or docetaxel. BMC Cancer 8:97","journal-title":"BMC Cancer"},{"key":"2751_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/annonc\/mdl435","volume":"18","author":"J Bellmunt","year":"2007","unstructured":"Bellmunt J, Paz-Ares L, Cuello M, Cecere FL, Albiol S, Guillem V, Gallardo E, Carles J, Mendez P, de la Cruz JJ, Taron M, Rosell R, Baselga J, Spanish Oncology Genitourinary Group (2007) Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol 18:522\u2013528","journal-title":"Ann Oncol"},{"key":"2751_CR20","doi-asserted-by":"publisher","first-page":"e102112","DOI":"10.1371\/journal.pone.0102112","volume":"9","author":"TY Seiwert","year":"2014","unstructured":"Seiwert TY, Wang X, Heitmann J, Villegas-Bergazzi V, Sprott K, Finn S, O'Regan E, Farrow AD, Weichselbaum RR, Lingen MW, Cohen EEW, Stenson K, Weaver DT, Vokes EE (2014) DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. PLoS One 9:e102112","journal-title":"PLoS One"},{"key":"2751_CR21","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-11-0086","volume":"17","author":"A Vaezi","year":"2011","unstructured":"Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, Weaver DT, D'Andrea AD, Argiris A, Romkes M, Niedernhofer LJ, Grandis JR (2011) XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res 17:5513\u20135522","journal-title":"Clin Cancer Res"},{"key":"2751_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ijc.28454","volume":"134","author":"SB Hatch","year":"2014","unstructured":"Hatch SB, Swift LP, Caporali S, Carter R, Hill EJ, MacGregor TP et al (2014) XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection. Int J Cancer 134:1495\u20131503","journal-title":"Int J Cancer"},{"key":"2751_CR23","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.1007\/s13277-014-1959-0","volume":"35","author":"J Li","year":"2014","unstructured":"Li J, Zuo X, Lv X, Kong F, Xu W, Yang S (2014) Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population. Tumour Biol 35:7569\u20137574","journal-title":"Tumour Biol"},{"key":"2751_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MCP.0b013e32816b5c63","volume":"13","author":"KA Olaussen","year":"2007","unstructured":"Olaussen KA, Mountzios G, Soria JC (2007) ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer. Curr Opin Pulm Med 13:284\u2013289","journal-title":"Curr Opin Pulm Med"},{"key":"2751_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-59745-545-9_4","volume":"576","author":"AM Dancau","year":"2010","unstructured":"Dancau AM, Simon R, Mirlacher M, Sauter G (2010) Tissue microarrays. Methods Mol Biol 576:49\u201360","journal-title":"Methods Mol Biol"},{"key":"2751_CR26","first-page":"803","volume":"59","author":"L Bubendorf","year":"1999","unstructured":"Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 59:803\u2013806","journal-title":"Cancer Res"},{"key":"2751_CR27","first-page":"47","volume":"4","author":"A Vaezi","year":"2011","unstructured":"Vaezi A, Feldman CH, Niedernhofer LJ (2011) ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer. Pharmgenomics Pers Med 4:47\u201363","journal-title":"Pharmgenomics Pers Med"},{"key":"2751_CR28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijrobp.2006.06.029","volume":"66","author":"J Carles","year":"2006","unstructured":"Carles J, Monzo M, Amat M, Jansa S, Artells R, Navarro A, Foro P, Alameda F, Gayete A, Gel B, Miguel M, Albanell J, Fabregat X (2006) Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys 66:1022\u20131030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2751_CR29","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.22851","volume":"121","author":"CC Ragin","year":"2007","unstructured":"Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813\u20131820","journal-title":"Int J Cancer"},{"key":"2751_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6750-12-88","volume":"12","author":"D Ma","year":"2012","unstructured":"Ma D, Baruch D, Shu Y, Yuan K, Sun Z, Ma K, Hoang T, Fu W, Min L, Lan ZS, Wang F, Mull L, He WW (2012) Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology. BMC Biotechnol 12:88","journal-title":"BMC Biotechnol"},{"key":"2751_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00432-012-1318-8","volume":"139","author":"V Bisof","year":"2013","unstructured":"Bisof V, Jakovcevic A, Seiwerth S, Rakusic Z, Gasparov S (2013) Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy. J Cancer Res Clin Oncol 139:187\u2013194","journal-title":"J Cancer Res Clin Oncol"},{"key":"2751_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1479-5876-9-31","volume":"9","author":"TJ Chiu","year":"2011","unstructured":"Chiu TJ, Chen CH, Chien CY, Li SH, Tsai HT, Chen YJ (2011) High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. J Transl Med 9:31","journal-title":"J Transl Med"},{"key":"2751_CR33","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1056\/NEJMc070742","volume":"356","author":"LJ Niedernhofer","year":"2007","unstructured":"Niedernhofer LJ, Bhagwat N, Wood RD (2007) ERCC1 and non-small-cell lung cancer. N Engl J Med 356:2538\u20132540 author reply 40-1","journal-title":"N Engl J Med"},{"key":"2751_CR34","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1158\/0008-5472.CAN-09-1237","volume":"69","author":"NR Bhagwat","year":"2009","unstructured":"Bhagwat NR, Roginskaya VY, Acquafondata MB, Dhir R, Wood RD, Niedernhofer LJ (2009) Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res 69:6831\u20136838","journal-title":"Cancer Res"},{"key":"2751_CR35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa1214271","volume":"368","author":"L Friboulet","year":"2013","unstructured":"Friboulet L, Olaussen KA, Pignon JP, Shepherd FA, Tsao MS, Graziano S, Kratzke R, Douillard JY, Seymour L, Pirker R, Filipits M, Andr\u00e9 F, Solary E, Ponsonnailles F, Robin A, Stoclin A, Dorvault N, Commo F, Adam J, Vanhecke E, Saulnier P, Thomale J, le Chevalier T, Dunant A, Rousseau V, le Teuff G, Brambilla E, Soria JC (2013) ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med 368:1101\u20131110","journal-title":"N Engl J Med"},{"key":"2751_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hed.21817","volume":"34","author":"D Hao","year":"2012","unstructured":"Hao D, Lau HY, Eliasziw M, Box A, Diaz R, Klimowicz AC, Shin B, Lees-Miller SP, Magliocco AM (2012) Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status. Head Neck 34:785\u2013791","journal-title":"Head Neck"},{"key":"2751_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.soc.2015.03.001","volume":"24","author":"EM Rettig","year":"2015","unstructured":"Rettig EM, D\u2019Souza G (2015) Epidemiology of head and neck cancer. Surg Oncol Clin N Am 24:379\u2013396","journal-title":"Surg Oncol Clin N Am"},{"key":"2751_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.soc.2015.03.014","volume":"24","author":"DA Clump","year":"2015","unstructured":"Clump DA, Bauman JE, Ferris RL (2015) Cancer of the oropharynx. Surg Oncol Clin N Am 24:509\u2013520","journal-title":"Surg Oncol Clin N Am"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2751-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-018-2751-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2751-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T19:14:20Z","timestamp":1574968460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-018-2751-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2751"],"URL":"https:\/\/doi.org\/10.1007\/s00784-018-2751-0","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"n.a.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}